Subject index volume 57 (1994)

European Journal and Reproductive

ELSEVIER

of Obstetrics & Gynecology Biology 57 (1994) 225-226

Subject index Volume

57 (1994)

Abortion 57. 19. 171 Actinomycosis 57. 5 I Adenocarcinoma 57, 161 Albumin 57. 181 Amino acids 57. II7 Anaerobic bacteria 57. 85 Appendiceal involvement 57. 29 Arachidonic acid 57. 189

Fetal membrane 57, 123 Fetal outcome 57. 79, 215 Fetal well-being 57. 73 Fetus 57. I89 Flush 57, 137

Assessment 57, 179 Attitude 57. 95 Attitudes 57. 201

Glucose 57, I I7 Glycosylated hemoglobin 57. 2 I I GnRH (agonists) 57, 137 Gonadotrophin-releasing hormone analogue

Benefits to patients 57, 141 Birthweight 57, I3 Bleeding pattern 57. 37 Breast 57, 33

Gonadotrophins 57, I95 Grading 57. I61

CA-125 57. 175 Caesarean section 57, 54 2-Cell mouse embryos 57. 195 Cervix 57. 157 Cesarean Chlamydia

section

57. 7

trachomatis

Heparin

57. 51 57. 149

Diabetic retinopathy 57, 21 I Docosahexaenoic acid 57, I89 Doppler ultrasound 57, I I I Doppler velocimetry 57. I I7 Ectopic pregnancy 57, 91 Eicosapentaenoic acid 57. I89 Electromyography 57, I57 Endometrial ablation 57, 179 Endometrial cancer 57. 167 Endometrium 57, 37 Erythrocyte count 57, 25 Estrogens 57. 103

57. 21 I

57, 195

57, 56

HIV infection 57, I3 Hot flushes 57, 103 Human 57, I81 Hypertenstion 57. 2 I5 Hypoxanthine Hysteroscopy

block 57. 195 57, I7 I

IL-I 57, 149 IL-IRA 57. 149 IL-6 57. 149 IL-6R 57, 149 Indices 57. 25 Infant, premature 57. I9 Infertility 57. I I I Interference with pulsatile GnRH Intrauterine adhesions 57, I71

0

1994 Elsevier Science Ireland

pattern

57. 137

Intrauterine contraceptive device 57. 51 Intrauterine growth retardation 57, I89 3-Isobutyl-I-methylxanthine (IBMX) 57. 195 Labour 57, 157 Lactate 57, I I7 Laparoscopic removal

57. 209

Menopause 57, 37 Menstrual loss 57, 179 Monitoring 57, 175 Mother 57, I89 Multiple Newborn

Fallopian Tube 57. I61 Fatty acids 57, 189 Fetal acid-base status 57. 73 Fetal distress 57, 73

0028-2243/941.SO7.00

57. 201 diabetes

57, 85

Chronic salpingitis 57. 91 Climacteric 57. 95 Climacteric syndrome 57. 103 Compression deformity 57. I Computed tomography 57. 56 Consanguinity 57. I9 Contraceptive use 57, 201 Dalkon Delivery

Germany Gestational

pregnancy

57. 65

57, I89

Obstetric hemorrhage 57. 129 Opinion 57, 95 Ovarian cancer 57. 29. 175 Ltd. All rights reserved

226

Ovarian

Subject

vein

57. 56

Partners 57. 95 q-PEG 57. 31 Pelvic inflammatory Perinatal mortality

disease 57, 79

57. 85

Perinatal registry 57. 79 Phagocytic function 57, 43 Placenta percreta 57, 129 Plasma 57, 189 Polymorphonuclear leukocytes 57. 43 Postoperative morbidity 57. 7 Postpartum 57. 56 Pregnancy 57, 25. 43, 149, 215 Pregnancy complications 57, I9 Pregnancy-induced hypertension 57, 47 Premature delivery 57, 13 Prematurity 57, 7 Prenatal care 57, 79. I9 Preterm labor 57, 65 Professional/political issues 57, I41 Prostacyclin 57. 47 Prostasomes 57, 181 Pulmonary edema 57, 65 Pulmonary hypoplasia 57, I Pulse oximetry Radiotherapy

57, 73 57. 33

index / Eur. J. Ohsrrt.

Gynrcol.

Reprod.

Bid.

57 (1994)

225-226

a-Receptor activity 57, 137 Recurrence 57. 167 Relaxin 57, 123 Retained gauze 57, 209 Risk factors 57, 167 Risk factors during pregnancy Ruptured membranes 57. 1 Salpingitis isthmica nodosa Sarcoma 57, 33 Septum 57. 171 Smoking 57. 25 Sperm motility 57, 181 Staging 57. 29, 161 Stearic acid 57. 189 Stiffness 57, 123 Surgical staging 57, 167 Survival 57. I61 Tensile strength 57, 123 Tetranectin 57, 175 Thrombophlebitis Thromboxane A, Tocolysis 57, 65

57, 56 57, 47

Umbilical artery 57, I17 Urinary incontinence 57, 54 Vesicocervical

fistula

57. 54

57. 79

57. 91